PRFX
PRF Technologies Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$0.97
−1.14%Margins
Gross margin
-311.8%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-98.5%
Return on equity
-70.1%
Return on assets
-103.5%
Return on invested capital
0.00x
Asset turnover
-$6.9M
Cash from operations
$1.18
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025